Method for the treatment or prevention of disorders of the skin or exoskeleton, e.g. hair growth deficiency, acne or skin cancer, comprises administration of peroxisome proliferator activated receptor ligands, e.g. rosiglitazone

摘要

The use of compounds (I), which interact with at least one peroxisome proliferator activated receptor (PPAR) subtype, for the production of medicaments for the treatment or prophylaxis of disorders of the skin or exoskeleton.